α and 1–β [Power / Sample Size]

posted by Yura – Belarus, 2017-12-28 07:50 (2172 d 22:05 ago) – Posting: # 18108
Views: 32,675

Hi Helmut,

❝ Although the study was performed with 28 subjects for ~81% power, the chance to get a post hoc power of ≥ 90% is ~23% and ≥ 95% is ~10%. That’s clearly not “forced BE” and none of these studies should be questioned by regulators.


You are considering the power after the study at n = 28 (which were calculated before the study: GMR=0.95, CV=0.25, β=0.80). The question is whether it is possible to carry out a study at n = 50 and will this be forced bioequivalence?
Regards

Complete thread:

UA Flag
Activity
 Admin contact
22,822 posts in 4,786 threads, 1,633 registered users;
26 visitors (0 registered, 26 guests [including 8 identified bots]).
Forum time: 05:55 CET (Europe/Vienna)

A scientist’s aim in a discussion with his colleagues
is not to persuade, but to clarify.    Leo Szilard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5